OPKO Health Price to Book Ratio 2010-2024 | OPK
Historical price to book ratio values for OPKO Health (OPK) over the last 10 years. The current price to book ratio for OPKO Health as of February 20, 2025 is 0.83.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| OPKO Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-02-21 | 1.68 | 0.82 | |
| 2024-09-30 | 1.49 | $2.06 | 0.72 |
| 2024-06-30 | 1.25 | $2.00 | 0.62 |
| 2024-03-31 | 1.20 | $1.80 | 0.67 |
| 2023-12-31 | 1.51 | $1.80 | 0.84 |
| 2023-09-30 | 1.60 | $1.87 | 0.86 |
| 2023-06-30 | 2.17 | $1.99 | 1.09 |
| 2023-03-31 | 1.46 | $2.01 | 0.73 |
| 2022-12-31 | 1.25 | $2.02 | 0.62 |
| 2022-09-30 | 1.89 | $2.11 | 0.90 |
| 2022-06-30 | 2.53 | $2.23 | 1.14 |
| 2022-03-31 | 3.44 | $2.37 | 1.45 |
| 2021-12-31 | 4.81 | $2.47 | 1.95 |
| 2021-09-30 | 3.65 | $2.59 | 1.41 |
| 2021-06-30 | 4.05 | $2.56 | 1.58 |
| 2020-12-31 | 3.95 | $2.49 | 1.58 |
| 2020-09-30 | 3.69 | $2.42 | 1.52 |
| 2020-06-30 | 3.41 | $2.37 | 1.44 |
| 2020-03-31 | 1.34 | $2.31 | 0.58 |
| 2019-12-31 | 1.47 | $2.41 | 0.61 |
| 2021-03-31 | 4.29 | $2.53 | 1.69 |
| 2019-09-30 | 2.09 | $2.67 | 0.78 |
| 2019-06-30 | 2.44 | $2.78 | 0.88 |
| 2019-03-31 | 2.61 | $2.86 | 0.91 |
| 2018-12-31 | 3.01 | $3.06 | 0.99 |
| 2018-09-30 | 3.46 | $3.20 | 1.08 |
| 2018-06-30 | 4.70 | $3.24 | 1.45 |
| 2018-03-31 | 3.17 | $3.26 | 0.97 |
| 2017-12-31 | 4.90 | $3.30 | 1.49 |
| 2017-09-30 | 6.86 | $3.73 | 1.84 |
| 2017-06-30 | 6.58 | $3.77 | 1.75 |
| 2017-03-31 | 8.00 | $3.77 | 2.12 |
| 2016-12-31 | 9.30 | $3.75 | 2.48 |
| 2016-09-30 | 10.59 | $3.78 | 2.80 |
| 2016-06-30 | 9.34 | $3.68 | 2.54 |
| 2016-03-31 | 10.39 | $3.65 | 2.85 |
| 2015-12-31 | 10.05 | $3.63 | 2.77 |
| 2015-09-30 | 8.41 | $3.61 | 2.33 |
| 2015-06-30 | 16.08 | $1.78 | 9.01 |
| 2015-03-31 | 14.17 | $1.77 | 7.99 |
| 2014-12-31 | 9.99 | $1.93 | 5.17 |
| 2014-09-30 | 8.51 | $2.06 | 4.14 |
| 2014-06-30 | 8.84 | $2.14 | 4.12 |
| 2013-12-31 | 8.44 | $2.12 | 3.99 |
| 2013-09-30 | 8.81 | $2.13 | 4.13 |
| 2013-06-30 | 7.10 | $0.93 | 7.65 |
| 2013-03-31 | 7.63 | $0.95 | 8.03 |
| 2012-12-31 | 4.81 | $0.59 | 8.15 |
| 2014-03-31 | 9.32 | $2.01 | 4.63 |
| 2012-09-30 | 4.18 | $0.49 | 8.45 |
| 2012-06-30 | 4.60 | $0.51 | 8.97 |
| 2012-03-31 | 4.73 | $0.53 | 9.01 |
| 2011-12-31 | 4.90 | $0.54 | 9.06 |
| 2011-09-30 | 4.33 | $0.36 | 12.07 |
| 2011-06-30 | 3.69 | $0.39 | 9.56 |
| 2011-03-31 | 3.73 | $0.43 | 8.60 |
| 2010-12-31 | 3.67 | $0.09 | 40.64 |
| 2010-09-30 | 2.24 | $0.08 | 28.39 |
| 2010-06-30 | 2.26 | $0.20 | 11.52 |
| 2010-03-31 | 1.98 | $0.22 | 9.05 |
| 2009-12-31 | 1.83 | $0.12 | 14.70 |
| 2009-09-30 | 2.28 | $0.25 | 8.99 |
| 2009-06-30 | 1.77 | $0.15 | 11.49 |
| 2009-03-31 | 0.98 | $-0.04 | -25.26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.140B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $216.048B | 99.11 |
| Thermo Fisher Scientific (TMO) | United States | $205.720B | 24.60 |
| Alcon (ALC) | Switzerland | $44.180B | 29.56 |
| Edwards Lifesciences (EW) | United States | $44.064B | 28.51 |
| IDEXX Laboratories (IDXX) | United States | $37.082B | 42.44 |
| DexCom (DXCM) | United States | $34.912B | 54.15 |
| IQVIA Holdings (IQV) | United States | $34.165B | 18.93 |
| Mettler-Toledo (MTD) | United States | $27.257B | 31.66 |
| Waters (WAT) | United States | $22.611B | 32.08 |
| STERIS (STE) | Ireland | $21.693B | 24.81 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.328B | 0.00 |
| Hologic (HOLX) | United States | $14.433B | 15.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.462B | 13.82 |
| Penumbra (PEN) | United States | $11.675B | 105.62 |
| Sysmex ADR (SSMXY) | Japan | $11.519B | 36.12 |
| Globus Medical (GMED) | United States | $11.454B | 26.79 |
| Masimo (MASI) | United States | $9.488B | 45.91 |
| Glaukos (GKOS) | United States | $8.676B | 0.00 |
| Teleflex (TFX) | United States | $8.134B | 12.97 |
| Inari Medical (NARI) | United States | $4.682B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.536B | 25.51 |
| PROCEPT BioRobotics (PRCT) | United States | $3.412B | 0.00 |
| Veracyte (VCYT) | United States | $3.181B | 95.46 |
| Nihon Kohden (NHNKY) | Japan | $2.671B | 14.60 |
| LivaNova (LIVN) | United Kingdom | $2.606B | 15.04 |
| TransMedics (TMDX) | United States | $2.532B | 80.27 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 21.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.110B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.700B | 8.88 |
| Alphatec Holdings (ATEC) | United States | $1.512B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.230B | 0.00 |
| RxSight (RXST) | United States | $1.222B | 0.00 |
| Artivion (AORT) | United States | $1.208B | 80.06 |
| Paragon 28 (FNA) | United States | $1.093B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.894B | 0.00 |
| AxoGen (AXGN) | United States | $0.814B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.793B | 17.33 |
| SiBone (SIBN) | United States | $0.755B | 0.00 |
| IRadimed (IRMD) | United States | $0.724B | 38.09 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.711B | 12.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.692B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.602B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.590B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.497B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.484B | 10.64 |
| ClearPoint Neuro (CLPT) | United States | $0.481B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.429B | 0.00 |
| NeuroPace (NPCE) | United States | $0.425B | 0.00 |
| CVRx (CVRX) | United States | $0.365B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.363B | 19.47 |
| Anteris Technologies Global (AVR) | Australia | $0.297B | 0.00 |
| Inogen (INGN) | United States | $0.245B | 0.00 |
| Accuray (ARAY) | United States | $0.222B | 0.00 |
| Nevro (NVRO) | United States | $0.215B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.201B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.178B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.158B | 0.00 |
| Neuronetics (STIM) | United States | $0.146B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.140B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.129B | 0.00 |
| LENSAR (LNSR) | United States | $0.115B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.091B | 13.90 |
| Lucid Diagnostics (LUCD) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.081B | 0.00 |
| Hyperfine (HYPR) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.062B | 32.14 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.040B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |